Walpoth B H, Volken U, Nydegger U, Jutzi H, Gersbach P, Leupi F, Schüpbach P, Althaus U
Klinik für Thorax-, Herz- und Gefässchirurgie, Inselspital Bern.
Helv Chir Acta. 1990 Oct;57(2):385-8.
In a prospective randomized study 10 patients received their shed mediastinal blood after elective coronary artery bypass surgery and were compared to 10 control patients without retransfusion. The quality assessment can be summarized as follows (mean +/- 1 SD): 1. Hemoglobin concentration of the shed blood was 9.6 +/- 1.45 g/dl. 2. The energy rich phosphate compounds of the shed blood erythrocytes were 2.6 +/- 0.8 mumol/gHb ATP (70% of the patients preoperative value) and 14.8 +/- 4.2 mumol/gHb 2.3-DPG (normal). 3. Proteins, immunoglobulins and especially albumin in the shed blood were not significantly different from the patients own values. 4. No electrolyte changes, safe for a slight increase in potassium (5.7 +/- 0.7 mmol/l). 5. The activated clotting time of the patient did not change during retransfusion. 7. Plasma free hemoglobin was elevated to 211.1 +/- 44.3 mg/dl in the shed blood; however, no significant increase could be noted in the retransfused patients and no hemoglobinuria occurred. Postoperative retransfusion of shed mediastinal blood is a simple and safe method of autologous transfusion early after cardiac surgery and should be combined with other methods of blood salvage. The qualitative advantages of blood retransfusion consist in the absence of storage damage and in the preservation of autologous proteins and immunoglobulins.
在一项前瞻性随机研究中,10例患者在择期冠状动脉搭桥手术后接受了纵隔引流血回输,并与10例未进行回输的对照患者进行比较。质量评估总结如下(均值±1标准差):1. 引流血的血红蛋白浓度为9.6±1.45g/dl。2. 引流血红细胞中的高能磷酸化合物为2.6±0.8μmol/gHb ATP(为患者术前值的70%)和14.8±4.2μmol/gHb 2,3-DPG(正常)。3. 引流血中的蛋白质、免疫球蛋白尤其是白蛋白与患者自身值无显著差异。4. 除钾略有升高(5.7±0.7mmol/L)外,无电解质变化。5. 患者在回输过程中活化凝血时间未改变。7. 引流血中血浆游离血红蛋白升高至211.1±44.3mg/dl;然而,回输患者中未观察到显著升高,也未发生血红蛋白尿。心脏手术后早期纵隔引流血的术后回输是一种简单安全的自体输血方法,应与其他血液回收方法联合使用。回输血的质量优势在于不存在储存损伤以及保留了自体蛋白质和免疫球蛋白。